169 related articles for article (PubMed ID: 12754287)
21. Dynamic epigenetic regulation of initial O-glycosylation by UDP-N-Acetylgalactosamine:Peptide N-acetylgalactosaminyltransferases. site-specific glycosylation of MUC1 repeat peptide influences the substrate qualities at adjacent or distant Ser/Thr positions.
Hanisch FG; Müller S; Hassan H; Clausen H; Zachara N; Gooley AA; Paulsen H; Alving K; Peter-Katalinic J
J Biol Chem; 1999 Apr; 274(15):9946-54. PubMed ID: 10187769
[TBL] [Abstract][Full Text] [Related]
22. Immunolocalisation of members of the polypeptide N-acetylgalactosaminyl transferase (ppGalNAc-T) family is consistent with biologically relevant altered cell surface glycosylation in breast cancer.
Brooks SA; Carter TM; Bennett EP; Clausen H; Mandel U
Acta Histochem; 2007; 109(4):273-84. PubMed ID: 17448526
[TBL] [Abstract][Full Text] [Related]
23. ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues.
Marcos NT; Bennett EP; Gomes J; Magalhaes A; Gomes C; David L; Dar I; Jeanneau C; DeFrees S; Krustrup D; Vogel LK; Kure EH; Burchell J; Taylor-Papadimitriou J; Clausen H; Mandel U; Reis CA
Front Biosci (Elite Ed); 2011 Jun; 3(4):1443-55. PubMed ID: 21622148
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells.
Brockhausen I; Yang JM; Burchell J; Whitehouse C; Taylor-Papadimitriou J
Eur J Biochem; 1995 Oct; 233(2):607-17. PubMed ID: 7588808
[TBL] [Abstract][Full Text] [Related]
25. Expression of polypeptide GalNAc-transferases in stratified epithelia and squamous cell carcinomas: immunohistological evaluation using monoclonal antibodies to three members of the GalNAc-transferase family.
Mandel U; Hassan H; Therkildsen MH; Rygaard J; Jakobsen MH; Juhl BR; Dabelsteen E; Clausen H
Glycobiology; 1999 Jan; 9(1):43-52. PubMed ID: 9884405
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells.
Carvalho AS; Harduin-Lepers A; Magalhães A; Machado E; Mendes N; Costa LT; Matthiesen R; Almeida R; Costa J; Reis CA
Int J Biochem Cell Biol; 2010 Jan; 42(1):80-9. PubMed ID: 19781661
[TBL] [Abstract][Full Text] [Related]
27. The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1.
Dalziel M; Whitehouse C; McFarlane I; Brockhausen I; Gschmeissner S; Schwientek T; Clausen H; Burchell JM; Taylor-Papadimitriou J
J Biol Chem; 2001 Apr; 276(14):11007-15. PubMed ID: 11118434
[TBL] [Abstract][Full Text] [Related]
28. Mucin-type O-glycans in tears of normal subjects and patients with non-Sjögren's dry eye.
Guzman-Aranguez A; Mantelli F; Argüeso P
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4581-7. PubMed ID: 19407012
[TBL] [Abstract][Full Text] [Related]
29. In vitro synthesis of mucin-type O-glycans using saccharide primers comprising GalNAc-Ser and GalNAc-Thr residues.
Sakura R; Nagai K; Yagi Y; Takahashi Y; Ide Y; Yagi Y; Yamamoto D; Mizuno M; Sato T
Carbohydr Res; 2022 Jan; 511():108495. PubMed ID: 35026558
[TBL] [Abstract][Full Text] [Related]
30. Loss of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 and reduced O-glycosylation in colon carcinoma cells selected for hepatic metastasis.
Kato K; Takeuchi H; Kanoh A; Miyahara N; Nemoto-Sasaki Y; Morimoto-Tomita M; Matsubara A; Ohashi Y; Waki M; Usami K; Mandel U; Clausen H; Higashi N; Irimura T
Glycoconj J; 2010 Feb; 27(2):267-76. PubMed ID: 20077002
[TBL] [Abstract][Full Text] [Related]
31. Products of Chemoenzymatic Synthesis Representing MUC1 Tandem Repeat Unit with T-, ST- or STn-antigen Revealed Distinct Specificities of Anti-MUC1 Antibodies.
Yoshimura Y; Denda-Nagai K; Takahashi Y; Nagashima I; Shimizu H; Kishimoto T; Noji M; Shichino S; Chiba Y; Irimura T
Sci Rep; 2019 Nov; 9(1):16641. PubMed ID: 31719620
[TBL] [Abstract][Full Text] [Related]
32. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
[TBL] [Abstract][Full Text] [Related]
33. Redefined substrate specificity of ST6GalNAc II: a second candidate sialyl-Tn synthase.
Kono M; Tsuda T; Ogata S; Takashima S; Liu H; Hamamoto T; Itzkowitz SH; Nishimura S; Tsuji S
Biochem Biophys Res Commun; 2000 May; 272(1):94-7. PubMed ID: 10872809
[TBL] [Abstract][Full Text] [Related]
34. The lectin domain of the polypeptide GalNAc transferase family of glycosyltransferases (ppGalNAc Ts) acts as a switch directing glycopeptide substrate glycosylation in an N- or C-terminal direction, further controlling mucin type O-glycosylation.
Gerken TA; Revoredo L; Thome JJ; Tabak LA; Vester-Christensen MB; Clausen H; Gahlay GK; Jarvis DL; Johnson RW; Moniz HA; Moremen K
J Biol Chem; 2013 Jul; 288(27):19900-14. PubMed ID: 23689369
[TBL] [Abstract][Full Text] [Related]
35. Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3.
Wandall HH; Hassan H; Mirgorodskaya E; Kristensen AK; Roepstorff P; Bennett EP; Nielsen PA; Hollingsworth MA; Burchell J; Taylor-Papadimitriou J; Clausen H
J Biol Chem; 1997 Sep; 272(38):23503-14. PubMed ID: 9295285
[TBL] [Abstract][Full Text] [Related]
36. GALNT11 as a new molecular marker in chronic lymphocytic leukemia.
Libisch MG; Casás M; Chiribao M; Moreno P; Cayota A; Osinaga E; Oppezzo P; Robello C
Gene; 2014 Jan; 533(1):270-9. PubMed ID: 24076351
[TBL] [Abstract][Full Text] [Related]
37. Expression of polypeptide GalNAc-transferases in hematopoietic stem/progenitor cells.
Cheng L; Wang X; Tan M; Zhou X; Wang Q
Cell Biol Int; 2004; 28(8-9):635-40. PubMed ID: 15350598
[TBL] [Abstract][Full Text] [Related]
38. Cloning, expression and properties of porcine trachea UDP-galnac: polypeptide N-acetylgalactosaminyl transferase.
Sangadala S; Swain JB; McNear A; Mendicino J
Mol Cell Biochem; 2004 Nov; 266(1-2):117-26. PubMed ID: 15646032
[TBL] [Abstract][Full Text] [Related]
39. Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells.
Huang J; Byrd JC; Yoon WH; Kim YS
Oncol Res; 1992; 4(11-12):507-15. PubMed ID: 1284381
[TBL] [Abstract][Full Text] [Related]
40. UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker.
Berois N; Mazal D; Ubillos L; Trajtenberg F; Nicolas A; Sastre-Garau X; Magdelenat H; Osinaga E
J Histochem Cytochem; 2006 Mar; 54(3):317-28. PubMed ID: 16260590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
